Literature DB >> 16243592

The general practitioner's approach to irritable bowel syndrome: from intention to practice.

M Bellini1, C Tosetti, F Costa, S Biagi, C Stasi, A Del Punta, P Monicelli, M G Mumolo, A Ricchiuti, P Bruzzi, S Marchi.   

Abstract

BACKGROUND: Although general practitioners play a critical role in the management of irritable bowel syndrome because they deal with the most patients, guidelines are developed mainly by specialists. AIMS: To evaluate the clinical features of irritable bowel patients and the general practitioners' approach to irritable bowel syndrome in Italy. SUBJECTS AND METHODS: A questionnaire focusing on the management of this syndrome was completed by 28 general practitioners. Clinical features and diagnostic and treatment measures taken in 229 patients were analysed.
RESULTS: Only 35.7% of the general practitioners were familiar with the Rome II criteria. Changes in bowel habits and abdominal pain/discomfort were the most common symptoms. Constipation (74.2%) was more frequent as the main symptom than diarrhoea. Routine blood tests (76.4%) and abdominal ultrasound (42.2%) were requested more frequently than colonoscopy (31.1%). At least one specialist consultation was recommended in 63.3% of patients. Drugs (mainly antispasmodics) were prescribed more frequently for diarrhoea (91.4%) than for constipation (55.7%).
CONCLUSIONS: General practitioners are little acquainted with the Rome II criteria. Diagnostic tests and specialist consultations are often recommended; antispasmodics are the most frequently prescribed drug. Guidelines should be developed together by general practitioners and gastroenterologists to effectively manage patients at a lower cost.

Entities:  

Mesh:

Year:  2005        PMID: 16243592     DOI: 10.1016/j.dld.2005.06.011

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  14 in total

1.  Could gastrointestinal disorders differ in two close but divergent social environments?

Authors:  Ewa Grodzinsky; Claes Hallert; Tomas Faresjö; Elisabet Bergfors; Ashild Olsen Faresjö
Journal:  Int J Health Geogr       Date:  2012-02-06       Impact factor: 3.918

Review 2.  Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests?

Authors:  Francesco Costa; Maria Gloria Mumolo; Santino Marchi; Massimo Bellini
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

3.  Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease.

Authors:  Hubert Mönnikes; Robert C Heading; Holger Schmitt; Hubert Doerfler
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

4.  Evaluation of latent links between irritable bowel syndrome and sleep quality.

Authors:  Massimo Bellini; Angelo Gemignani; Dario Gambaccini; Simona Toti; Danilo Menicucci; Cristina Stasi; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Remo Bedini; Nicola de Bortoli; Santino Marchi
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

5.  Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.

Authors:  Massimo Bellini; Cesare Tosetti; Francesco Rettura; Riccardo Morganti; Christian Lambiase; Gabrio Bassotti; Pierfrancesco Visaggi; Andrea Pancetti; Edoardo Benedetto; Nicola de Bortoli; Paolo Usai-Satta; Rudi De Bastiani
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

6.  Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study.

Authors:  M Bellini; D Gambaccini; L Bazzichi; G Bassotti; M G Mumolo; B Fani; F Costa; A Ricchiuti; N De Bortoli; M Mosca; S Marchi; A Rossi
Journal:  Tech Coloproctol       Date:  2017-05-31       Impact factor: 3.781

Review 7.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  Management of chronic constipation in general practice.

Authors:  M Bellini; D Gambaccini; S Salvadori; C Tosetti; M T Urbano; F Costa; P Monicelli; M G Mumolo; A Ricchiuti; N De Bortoli; S Marchi
Journal:  Tech Coloproctol       Date:  2013-11-22       Impact factor: 3.781

9.  Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.

Authors:  Robert C Heading; Hubert Mönnikes; Anne Tholen; Holger Schmitt
Journal:  BMC Gastroenterol       Date:  2011-05-11       Impact factor: 3.067

10.  Psychosocial factors at work and in every day life are associated with irritable bowel syndrome.

Authors:  Ashild Faresjö; Ewa Grodzinsky; Saga Johansson; Mari-Ann Wallander; Toomas Timpka; Ingemar Akerlind
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 12.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.